EN | RU
EN | RU

Help Support

Back

Effect of dexmedetomidine analgesia on delirium in people recovering from orthopedic surgery

Effect of dexmedetomidine analgesia on delirium in people recovering from orthopedic surgery Effect of dexmedetomidine analgesia on delirium in people recovering from orthopedic surgery
Effect of dexmedetomidine analgesia on delirium in people recovering from orthopedic surgery Effect of dexmedetomidine analgesia on delirium in people recovering from orthopedic surgery

This double-blinded, placebo-controlled, randomized controlled trial assessed whether supplementing sufentanil intravenous analgesia with dexmedetomidine minimizes delirium in older people (aged 65–90 years) recovering from major orthopedic surgery.

See All

Key take away

In elderly people recovering from orthopedic surgery, supplementation of intravenous analgesia with low-dose dexmedetomidine didn't considerably decrease delirium. However, it led to improvements in postoperative analgesia and subjective sleep quality without triggering adverse events.

Background

This double-blinded, placebo-controlled, randomized controlled trial assessed whether supplementing sufentanil intravenous analgesia with dexmedetomidine minimizes delirium in older people (aged 65–90 years) recovering from major orthopedic surgery.

Method

The study recruited 712 participants scheduled for major orthopedic surgery. Postsurgery analgesia was offered by patient-controlled intravenous sufentanil, supplemented by randomly allocated dexmedetomidine (1.25 μg/mL, n=356) or placebo (n=356), for up to 3 days. The occurrence of delirium evaluated twice daily using Confusion Assessment Method was the major endpoint.

Considering secondary outcomes, the severity of pain was evaluated twice daily and sleep quality once daily, each with an 11-point scale [0 representing no pain/best possible sleep and 10 representing worst pain/worst possible sleep.

Result

Table 1 shows the occurrence of postoperative delirium in the study groups (relative risk 0.65, 95% Confidence Interval 0.36 to 1.18):


Dexmedetomidine was found to minimize pain both at rest (median difference -1 to 0 points) and with movement (-1 points) throughout the initial five postsurgery days. Furthermore, an improvement in the subjective sleep quality was noted during the initial three postsurgery days. Both the groups illustrated comparable occurrences of adverse events.

Conclusion

Dexmedetomidine remains an appropriate supplement for multimodal analgesia in older patients undergoing orthopedic surgery as it is associated with improvements in analgesia and quality of sleep.

Source:

BMC Anesthesiology

Article:

Impact of dexmedetomidine supplemented analgesia on delirium in patients recovering from orthopedic surgery: A randomized controlled trial

Authors:

Hong Hong et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: